ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX

Stock Information for Eagle Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eagle Pharmaceuticals Inc.

Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.